Disclosure Of Entity's Operating Segments [Text Block]

BerGenBio - Filing #5877180

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
848,000 NOK
354,000 NOK
Tax expense (income)
0 NOK
0 NOK
Profit (loss) before tax
139,282,000 NOK
190,401,000 NOK
Profit (loss)
139,282,000 NOK
139,282,000 NOK
190,401,000 NOK
190,401,000 NOK
Assets
155,796,000 NOK
174,335,000 NOK
Liabilities
33,095,000 NOK
46,859,000 NOK
Cash flows from (used in) operating activities
153,242,000 NOK
225,101,000 NOK
Cash flows from (used in) investing activities
3,688,000 NOK
3,055,000 NOK
Cash flows from (used in) financing activities
129,609,000 NOK
224,884,000 NOK
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.